NCT01869803 2018-03-02Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic LeukemiaWake Forest University Health SciencesApproved for marketing
NCT00423826 2016-02-29Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseBarbara Ann Karmanos Cancer InstituteNo longer available